Ovensa provides nanomedicine technology platforms, which deliver targeted oral therapy with mucosal and brain-barrier crossing properties. Ovensa focuses on developing personalized treatments for cancer and neurodegenerative diseases and on preventing antibiotic resistance.

Biotechnology

Health Care

Therapeutics

Ovensa Inc.

Stéphane Gagné

Alexandre Moquin

Ravin Narain

The Scientific Team at Ovensa Inc. conducts cutting-edge research and development to advance nanomedicine technology platforms, focusing on personalized treatments for cancer, neurodegenerative diseases, and antibiotic resistance. This team leverages their expertise to develop targeted oral therapies that can effectively cross mucosal and brain barriers, ensuring innovative and precise medical solutions.

Scientific Team

About

Team members